• Updated

Oncologists say the single-dose immunotherapy is currently approved for those with advanced stage 4 melanoma, who have not had success with other treatments. The process works by surgically removing a piece of the patient's tumor and then identifying specific cancer-fighting immune cells from it. From there, the cells are multiplied and re-infused through an IV. By doing this, the patient's own immune cells can go on to identify and fight the cancer.